Navigating late‐stage dementia: A perspective from the Alzheimer's Association

Author:

Clifford Kristen1,Moreno Monica1,Kloske Courtney M.1

Affiliation:

1. Alzheimer's Association Chicago Illinois USA

Abstract

AbstractAlzheimer's disease (AD) is the most common cause of dementia, a general term for memory loss and decline in other cognitive abilities enough to interfere with daily life. AD accounts for 60% to 80% of dementia cases. The late stage of AD tends to be the shortest stage and, on average, lasts 1 to 2 years. As this stage of the condition progresses, it requires continuous intensive long‐term care and around‐the‐clock intensive care. The Alzheimer's Association stands firm in its commitment to supporting individuals living with AD and other dementia, their care partners, and their health‐care providers as they navigate treatment and care decisions across the continuum of the disease. This article is a direct response to recently published works that run counter to the Association's viewpoint. It outlines the Association's perspective on crucial factors for consideration during late‐stage dementia care, including advanced directives, palliative care, nutrition, and legal considerations. It explores diverse perspectives from the field, differing from the Alzheimer's Association's stance. Last, it underscores resources available through the Alzheimer's Association, aiming to present a comprehensive perspective on late‐stage care for support and assistance to all involved.

Publisher

Wiley

Reference18 articles.

1. 2023 Alzheimer's disease facts and figures

2. Alzheimer’s Association® Dementia Care Practice Recommendations

3. Can an effective end‐of‐life intervention for advanced dementia be viewed as moral?

4. Timely dying in dementia: Use patients' judgments and broaden the concept of suffering

5. Alzheimer's Association.End‐of‐Life Decisions—Honoring the wishes of a person living with dementia 2022.https://www.alz.org/media/Documents/alzheimers-dementia-end-of-life-decisions-ts.pdf

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3